+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Patient, physician, and payment predictors of statin adherence



Patient, physician, and payment predictors of statin adherence



Medical Care 48(3): 196-202



Although many patient, physician, and payment predictors of adherence have been described, knowledge of their relative strength and overall ability to explain adherence is limited. To measure the contributions of patient, physician, and payment predictors in explaining adherence to statins. Retrospective cohort study using administrative data. A total of 14,257 patients insured by Horizon Blue Cross Blue Shield of New Jersey who were newly prescribed a statin cholesterol-lowering medication. Adherence to statin medication was measured during the year after the initial prescription, based on proportion of days covered. The impact of patient, physician, and payment predictors of adherence were evaluated using multivariate logistic regression. The explanatory power of these models was evaluated with C statistics, a measure of the goodness of fit. Overall, 36.4% of patients were fully adherent. Older patient age, male gender, lower neighborhood percent black composition, higher median income, and fewer number of emergency department visits were significant patient predictors of adherence. Having a statin prescribed by a cardiologist, a patient's primary care physician, or a US medical graduate were significant physician predictors of adherence. Lower copayments also predicted adherence. All of our models had low explanatory power. Multivariate models including patient covariates only had greater explanatory power (C = 0.613) than models with physician variables only (C = 0.566) or copayments only (C = 0.543). A fully specified model had only slightly more explanatory power (C = 0.633) than the model with patient characteristics alone. Despite relatively comprehensive claims data on patients, physicians, and out-of-pocket costs, our overall ability to explain adherence remains poor. Administrative data likely do not capture many complex mechanisms underlying adherence.

(PDF emailed within 0-6 h: $19.90)

Accession: 054891238

Download citation: RISBibTeXText

PMID: 19890219

DOI: 10.1097/MLR.0b013e3181c132ad


Related references

Predictors of Statin Adherence, Switching, and Discontinuation in the USAGE Survey Understanding Statin Use in America and Gaps in Patient Education. Journal of Clinical Lipidology 7(3): 245-246, 2013

Patient and physician predictors of hyperlipidemia screening and statin prescription. American Journal of Managed Care 24(8): E241-E248, 2018

Improving the physician-patient cardiovascular risk dialogue to improve statin adherence. Bmc Family Practice 10: 48, 2009

Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics. Journal of Managed Care Pharmacy 13(6): 487-496, 2007

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education. Journal of Clinical Lipidology 7(5): 472-483, 2014

Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists. Journal of the American Heart Association 6(10), 2018

Is the physician's adherence to prescription guidelines associated with the patient's socio-economic position? An analysis of statin prescription in South Sweden. Journal of Epidemiology and Community Health 64(8): 678-683, 2012

Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflammatory Bowel Diseases 15(8): 1233-1239, 2009

Medication adherence and healthcare disparities: impact of statin co-payment reduction. American Journal of Managed Care 21(10): 696-704, 2017

Physician estimates of adherence and the patient-physician relationship as a setting to improve adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 31 Suppl 3: S158-S162, 2003

Mo1103 Physician and Patient Factors As Potential Predictors of Non-Adherence to Colonoscopy Guidelines in an Integrated Managed Care System. Gastroenterology 144(5): S-578-S-579, 2013

Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics: the importance of physician-patient interaction and communication. Journal of the European Academy of Dermatology and Venereology 31(6): 1014-1020, 2017

Predictors of statin adherence. Current Cardiology Reports 13(6): 553-558, 2012

Patient-reported adherence to statin therapy, barriers to adherence, and perceptions of cardiovascular risk. Plos One 13(2): E0191817, 2018

Medicare Program; Merit-Based Incentive Payment System (MIPS) and Alternative Payment Model (APM) Incentive Under the Physician Fee Schedule, and Criteria for Physician-Focused Payment Models. Final rule with comment period. Federal Register 81(214): 77008-77831, 2016